Mendelian randomization investigation of the causal association between circulating cytokines and colorectal cancer

Author:

Yang Zhensong1,Zhang Menglai1,Zhang Yifei1,Tang Yutao1,Li Yanbao2,Zhang Yue2,Jian Mi1,Jiang Lixin1

Affiliation:

1. Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University

2. The Yeda Hospital of Yantai City

Abstract

Abstract Objective To explore the causal relationship between colorectal cancer risk and circulating cytokines and identify potential predictive biomarkers. Methods This study employed a bidirectional Mendelian randomization (MR) analysis based on data from genome-wide association (GWAS) studies of colorectal cancer from people of European ancestry. The genetic variants associated with 41 circulating cytokines exposed were selected as instrumental variables for this experiment. For robustness and consistency of findings, we conducted additional sensitivity analyses and reverse Mendelian randomization assessments. Results The analysis revealed a strong causal relationship between colorectal cancer occurrence and Vascular Endothelial Growth Factor (VEGF), Macrophage Colony Stimulating Factor (MCSF), Interleukin-12p70 (IL-12p70), Interleukin-13(IL-13), Interleukin-10 levels (IL-10) and Interleukin-7 levels (IL-7) and demonstrated partial consistency. Sensitivity analyses indicated that IL-12p70, IL-7 and VEGF are potential colorectal cancer predictive biomarkers. Conclusion This Mendelian randomized study offers valuable insights into the causal relationships between specific circulating cytokines and colorectal cancer risk. The identified cytokines may serve as predictive biomarkers, enabling the development of novel diagnostic, preventive, and therapeutic approaches, but further experimental validation of their potential as diagnostic biomarkers or cancer-related pharmacological targets is necessary.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. Identification of a biomarker panel for colorectal cancer diagnosis;Garcé“࿽a-Bilbao A;BMC Cancer,2012

3. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?;Hofman P;Ann Oncol,2019

4. Singh, R., M.K. Mishra and H. Aggarwal, Inflammation, Immunity, and Cancer. Mediators Inflamm, 2017. 2017: p. 6027305.

5. Why cancer and inflammation?;Rakoff-Nahoum S;Yale J Biol Med,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3